Editor Biography

Esam Z. Dajani

Esam Z. Dajani

IDDC Corporation
Adjunct Professor of Medicine
Loyola University Chicago
United States


Dr. Esam Z. Dajani, is the founder and president of International Drug Development Consultants (IDDC) Corporation, a Contract Research Organization (CRO) which provides scientific consulting services to pharmaceutical companies, law firms and governmental agencies. The scope of the consulting service includes clinical pharmacology, toxicology, drug development and regulatory affairs. He has directed worldwide clinical research and development at major pharmaceutical companies. He led the research teams that discovered and developed misoprostol (Cytotec), an anti-ulcer drug. 123 peer-reviewed biomedical articles, book chapters and patents. 133 presentations at national and international biomedical conferences. Since 1980, he held continuous academic appointments in pharmacology and in medicine. He is currently serving as Adjunct Professor of Medicine at Loyola University-Chicago. He taught pharmacology and toxicology to medical, dental and pharmacy students.

Research interest:
  • Clinical pharmacology
  • Gastrointestinal pharmacology
  • Central Nervous System Pharmacology
  • Prostaglandins
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Growth hormones (e.g., epidermal growth factor)
  • Cannabinoids
  • Narcotic Analgesics

Edupress The Best Education & University HTML Template Ever!Submit Manuscript